Concepedia

Marius Messemaker

MM

Statistics

Publications

7

Citations

1.7K

H-Index

7

Active since

2020

Affiliations

Harvard University(Current)

University of Geneva

Center for Systems Biology

Massachusetts General Hospital

The Netherlands Cancer Institute

Marius Messemaker is an author at Harvard University specializing in cancer immunology, immunology, and oncology.

ORCID

Publications per year

2020–2025

7

Publications

7

<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers

Ruben Bill, Pratyaksha Wirapati, Marius Messemaker et al. · Science · 2023 · 614 citations · Full text

, , +16

CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment

Mauro Di Pilato, Raphael Kfuri‐Rubens, Jasper N. Pruessmann et al. · Cell · 2021 · 468 citations · Full text

, , +17

A neutrophil response linked to tumor control in immunotherapy

Jeremy Gungabeesoon, Nicolas A. Gort-Freitas, Máté Kiss et al. · Cell · 2023 · 388 citations · Full text

, , +12

Tumor-Promoting Ly-6G+ SiglecFhigh Cells Are Mature and Long-Lived Neutrophils

Christina Pfirschke, Camilla Engblom, Jeremy Gungabeesoon et al. · Cell Reports · 2020 · 122 citations · Full text

, , +13

Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy

Marie Siwicki, Nicolas A. Gort-Freitas, Marius Messemaker et al. · Science Immunology · 2021 · 80 citations · Full text

, , +17

1–5 of 7